Introduction
Addison's disease or primary adrenocortical insufficiency is a rare endocrine disorder. 1 In the majority of cases, pathogenesis lies in idiopathic autoimmune adrenalitis, and 21-hydroxylase autoantibodies have been found in 80-90% of patients with idiopathic Addison's disease. 2 Addison's disease can have a varied presentation from non-specific symptoms of weakness, fatigue, nausea and abdominal pain to classic skin pigmentation and hypotensive shock associated with an Addisonian crisis. This case demonstrates the first documented case of a woman with Addison's disease with antenatally diagnosed complete fetal heart block. This may help to guide the management of future cases of fetal heart block with Addison's and other autoimmune conditions.
Case description
A 33-year-old G2 P1 (one previous normal vaginal delivery of a 3000-g live female infant) was referred to our unit for management because of maternal Addison's disease. This had been diagnosed 3 years prior to the background of weakness, weight loss and skin discolouration and was managed with hydrocortisone and fludrocortisone. Her first pregnancy was complicated by a postpartum haemorrhage after a normal vaginal delivery, resulting in an Addisonian crisis, which was managed with increased doses of hydrocortisone. This pregnancy was again complicated by an Addisonian crisis following a bout of gastroenteritis. After endocrine review, her steroid doses were again increased. Following a low risk first trimester screen and normal fetal anomaly scan, her care was booked through the high-risk unit at the Fetal Medicine Unit including a plan for stress steroids in the presence of any admission, acute illnesses or labour. At 28 weeks, during a planned fetal growth scan, an unexpected persistent fetal sinus bradycardia was identified at rates of 45-70 bpm. (Figure 1 ). The heart appeared structurally normal but enlarged (left ventricle minor Z-score 3.5 and right ventricle minor Z-score 2.6) with some trabeculation visible within the ventricular wall ( Figure 2 ). Review by a paediatric cardiologist confirmed a structurally normal heart with ventricular size and function within normal limits and complete heart block with a ventricular rate of 50 bpm and an atrial rate of 140 bpm.
Following this, close surveillance of fetal well-being with serial ultrasound was instigated.
A full autoimmune antibody screen was performed and confirmed negative status for anti-Ro (SSA) and anti-La (SSB) antibodies. A full course of corticosteroids was given with a plan for a trial of salbutamol if the ventricular rate decreased further and to deliver if there were signs of hydrops on ultrasound. Arrangements were made for delivery in a quaternary unit to allow for immediate postnatal paediatric cardiology intervention.
Fetal activity, growth and ventricular rate remained stable for the remainder of the pregnancy, and there was no ultrasound evidence of evolving cardiac pathology or fetal hydrops. Following a spontaneous pre-labour rupture of membranes at 37 weeks and 4 days gestation, an oxytocin-induced labour resulted in a normal vaginal delivery of a 3304-g (75th percentile for gestational age) live male infant with Apgar score of 7 1 9 5 and normal arterial and venous blood gases. The newborn was admitted to the Neonatal Intensive Care Unit for cardiac monitoring and was fitted for a pacemaker day 3 of life. He is currently thriving and meeting developmental milestones.
Discussion
Addison's disease was once considered a contraindication to pregnancy. corticosteroid supplementation, maternal mortality has been reduced from 45% in 1930 to 7% in 1948-1955 and 0.7% in 2000. 4 Non-treated Addison's disease reduces fertility and can also mimic other signs of early pregnancy; therefore, clinicians must be alert to atypical or prolonged presentations of hyperemesis that may Addison's disease congenital fetal heart block R. Orefice et al. Congenital fetal heart block is a rare condition affecting approximately 1 in 15 000 to 1 in 20 000 live births and is defined as a complete failure of normal conductions of atrial impulses to the ventricles. [6] [7] [8] Approximately half of the cases diagnosed prenatally are due to structural abnormalities such as atrial septal defects and atrial isomerism. 7 It is therefore important to exclude structural cardiac defects whenever a fetal arrhythmia is present during an ultrasound examination. Congenital fetal heart block is strongly associated with the presence of maternal autoimmune antibodies, which can cross the placenta, in particular, anti-Ro (SSA) and anti-La (SSB) antibodies. These antibodies are present in autoimmune conditions such as systemic lupus erythematosus, Sjögren's syndrome (SS) and rheumatoid arthritis. 7 In 1% to 5% of exposed fetuses, these antibodies can induce a fetal myocarditis destroying the conducting fibres of the fetal heart, resulting in complete heart block. 9, 10 Features of complete heart block usually manifest between 18 and 24 weeks of gestation. 7 Ultrasound plays an important role in diagnosis and surveillance of complete heart block. Diagnosis is made by motion mode (M-mode) or spectral Doppler techniques.
M-mode displays atrial and ventricular wall motion relative to time, thereby allowing determination of the relative timing of cardiac events. 6 When the M-mode line passes through the most contractile parts of the heart, namely, the free wall of the left ventricle, and the right atrial appendage, the best trace will be achieved ( Figure 3) . A slower sweep speed may be necessary to record a series of slower ventricular contractions. Spectral Doppler techniques require a more sophisticated level of interpretation and include simultaneous sampling of left ventricular inflow and outflow, simultaneous sampling of the aorta and superior vena cava and simultaneous sampling of the pulmonary artery and pulmonary vein. Fetal tissue Doppler imaging is another technique that can be used to assess atrial and ventricular movement.
9,11
Fetal surveillance with cardiotocography (CTG) is considered the best indicator of fetal stress due to poor perfusion; however, in the case of complete heart block, there is very little ventricular variability, making this test suboptimal. Ultrasound surveillance includes evaluation of cardiac function by assessment of cardiac size, tricuspid and mitral insufficiency and presence of fetal hydrops (ascites, pericardial effusions, pleural effusions and skin oedema). The slow ventricular rate is reflected in the spectral trace of the umbilical artery Doppler waveform. A long diastolic phase results in low diastolic velocity ( Figure 4) . As a consequence, Doppler indices such as the pulsatility index are increased, and normal reference ranges do not apply. Umbilical artery Doppler assessment therefore relies on poor prognostic features of absent or reversed end diastolic flow. 8 Poor prognostic factors for fetuses with heart block especially associated with structural heart disease include endocardial fibroelastosis and hydrops. 12 Treatment of the fetus with complete atrioventricular block is primarily expectant. In the absence of structural abnormalities, fetuses generally tolerate arrhythmias well when ventricular rates are greater than 60 bpm. 13 Attempts have been made to increase the fetal heart rate with administration of maternal beta-adrenergic agents and have been reserved for cases of fetal heart rate < 55 bpm or signs of decompensation, although this approach has not been evaluated by comparative studies. 14 Women with autoimmune conditions and anti-Ro (SSA) and anti-La (SSB) antibodies carry a 2-5% risk of having a child with congenital heart block. 7 To our knowledge, this is the first documented case of maternal Addison's disease with negative antibodies resulting in congenital fetal heart block. This case presented multiple diagnostic and management challenges and raised additional clinical questions. Congenital fetal heart block has never been reported in a case of Addison's disease, a known complex autoimmune disease, which raises the question whether there are other antibodies that may cause heart block. By following a previously documented approach to overcome monitoring challenges, 8 this case illustrates frequent ultrasound surveillance can optimise outcome. We hope that this case can help guide conservative management with close monitoring in cases of congenital heart block to avoid the short-term and long-term complications of iatrogenic preterm birth.
Conclusion
In this case, M-mode ultrasound identified the rare condition of congenital fetal heart block in a woman with Addison's disease who was SSA and SSB antibody negative. This case demonstrated the potential role for fetal echocardiography monitoring in women with autoimmune diseases previously not thought to be associated with congenital fetal heart clock.
